Clinical Response in Plaque Psoriasis Patients Switching from Etanercept to Certolizumab Pegol in a Phase 3, Randomized, Controlled Study

Main Article Content

M Augustin
J Wegtowska
M Lebwohl
C Paul
V Piguet
H Sofen
A Blauvelt
L Peterson
C Arendt
R Rolleri

Keywords

Abstract

Abstract not available.

 

Disclosures: Study sponsored by Dermira.

 

Copyright 2018 SKIN